|
|
|
HY-13266
|
| MedChemExpress |
|
10mg |
|
)
|
|
|
HY-13266A
|
| MedChemExpress |
|
50mg |
|
|
|
|
A5700-10
|
| ApexBio |
|
10 mg |
|
Description: IC50: 21 nm (CDK7) Normal progression through the cell cycle requires the sequential action of cyclin-dependent kinases CDK1, CDK2, CDK4, and CDK6.
|
|
|
|
|
|
A5700-5
|
| ApexBio |
|
5 mg |
|
Description: IC50: 21 nm (CDK7) Normal progression through the cell cycle requires the sequential action of cyclin-dependent kinases CDK1, CDK2, CDK4, and CDK6.
|
|
|
|
|
|
A5700-50
|
| ApexBio |
|
50 mg |
|
Description: IC50: 21 nm (CDK7) Normal progression through the cell cycle requires the sequential action of cyclin-dependent kinases CDK1, CDK2, CDK4, and CDK6.
|
|
|
|
|
|
|
 (OKEH05780))
|
|
|
OKEH05780
|
| Aviva Systems Biology |
|
96 Wells |
|
Description: Description of target: Involved in oxygen transport from the lung to the various peripheral tissues. ;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.448 ng/mL
|
|
|
|
|
BT222-BS
|
| Bio Basic |
|
1PK, 1000UNIT |
|
